DWA
LFCR icon

Dorsey Wright & Associates’s Lifecore Biomedical LFCR Stock Holding History

Dorsey Wright & Associates’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-932
Closed -$7K – 340
2020
Q2 		$7K Buy
+932
New +$9.62K ﹤0.01% 301

Other funds holding LFCR

LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Dorsey Wright & Associates's LFCR Position: Q3 2020 in Review

Dorsey Wright & Associates sold out of Lifecore Biomedical (LFCR) in Q3 2020, closing a stake of 932 shares — an estimated $7K sold.

Dorsey Wright & Associates first reported a position in LFCR in Q2 2020 and held it in 1 quarter. The position peaked at $7K in Q2 2020. 96 funds tracked by Wall St. Rank hold LFCR as of Q3 2020.

  • Dorsey Wright & Associates reported no remaining Lifecore Biomedical position as of Q3 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 932 Lifecore Biomedical shares in Q3 2020, an estimated $7K.
  • Dorsey Wright & Associates first reported a position in Lifecore Biomedical in Q2 2020 and held it in 1 quarter.
  • Dorsey Wright & Associates's Lifecore Biomedical position peaked at $7K in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2020.

Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.